| A review of brucellosis in Iran: epidemiology, risk factors, diagnosis, control, and prevention M Golshani, S Buozari Iranian biomedical journal 21 (6), 349, 2017 | 147 | 2017 |
| Genital tract infection in asymptomatic infertile men and its effect on semen quality M Golshani, S Taheri, G Eslami, RAA SOLEYMANI, F FALAH, H Goudarzi Iranian Journal of Public Health 35 (3), 81-84, 2006 | 67 | 2006 |
| Detection of Chlamydia trachomatis, Mycoplasma hominis and Ureaplasma urealyticum by multiplex PCR in semen sample of infertile men M Golshani, G Eslami, H Goudarzi, RAA SOLEYMANI, F Fayaz, ... IRANIAN JOURNAL OF PUBLIC HEALTH 36 (2), 50-57, 2007 | 51 | 2007 |
| Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen M Golshani, S Rafati, SD Siadat, M Nejati-Moheimani, F Shahcheraghi, ... Molecular immunology 66 (2), 384-391, 2015 | 32 | 2015 |
| Vaccination with recombinant L7/L12-truncated Omp31 protein induces protection against Brucella infection in BALB/c mice M Golshani, S Rafati, A Dashti, E Gholami, SD Siadat, M Oloomi, A Jafari, ... Molecular immunology 65 (2), 287-292, 2015 | 32 | 2015 |
| Comparison of potential protection conferred by three immunization strategies (protein/protein, DNA/DNA, and DNA/protein) against Brucella infection using … M Golshani, S Rafati, M Nejati-Moheimani, M Ghasemian, S Bouzari Veterinary microbiology 197, 47-52, 2016 | 18 | 2016 |
| In silico design, cloning and high level expression of L7/L12-TOmp31 fusion protein of Brucella antigens M Golshani, S Rafati, A Jahanian-Najafabadi, M Nejati-Moheimani, ... Research in pharmaceutical sciences 10 (5), 436-445, 2015 | 18 | 2015 |
| PCR detection and high risk typing of human papillomavirus DNA in cervical cancer in Iranian women G Eslami, M Golshani, M Rakhshan, F Fallah, H Goudarzi, A Taghavi Cancer Ther 6, 361-6, 2008 | 16 | 2008 |
| Evaluation of Poly (I: C) and combination of CpG ODN plus Montanide ISA adjuvants to enhance the efficacy of outer membrane vesicles as an acellular vaccine against Brucella … M Golshani, M Amani, F Amirzadeh, E Nazeri, SD Siadat, ... International Immunopharmacology 84, 106573, 2020 | 14 | 2020 |
| In silico analysis of Brucella abortus Omp2b and in vitro expression of SOmp2b M Golshani, N Vaeznia, M Sahmani, S Bouzari Clinical and experimental vaccine research 5 (1), 75, 2016 | 12 | 2016 |
| The study on relation of Human Papillomavirus with bladder transitional cell carcinoma G Eslami, M Golshani, M Rakhshon, F Fallah, H Goudarzi Cancer Therapy 6, 355-360, 2008 | 12 | 2008 |
| Multiple sclerosis patients and disease modifying therapies: impact on immune responses against COVID-19 and SARS-CoV-2 vaccination M Golshani, J Hrdý Vaccines 10 (2), 279, 2022 | 10 | 2022 |
| The Homeless youth and their exposure to Hepatitis B and Hepatitis C among in Tehran, Iran F Fallah, A Karimi, G Eslami, S Tabatabaii, H Goudarzi, RRA Moradi, ... Gene Ther Mol Biol 12 (1), 95-100, 2008 | 10 | 2008 |
| Comparison of the protective immunity elicited by a Brucella cocktail protein vaccine (rL7/L12+ rTOmp31+ rSOmp2b) in two different adjuvant formulations in BALB/c mice M Golshani, M Amani, SD Siadat, M Nejati-Moheimani, A Arsang, ... Molecular immunology 103, 306-311, 2018 | 9 | 2018 |
| Protein/Protein, DNA/DNA and DNA/Protein based vaccination strategies using truncated Omp2b against Brucella infection in BALB/c Mice M Golshani, S Rafati, M Nejati-Moheimani, S Pourabdi, A Arsang, ... International journal of medical microbiology 307 (4-5), 249-256, 2017 | 9 | 2017 |
| In silico analysis of Shiga toxins (Stxs) to identify new potential vaccine targets for Shiga toxin-producing Escherichia coli M Golshani, M Oloomi, S Bouzari In silico pharmacology 5 (1), 2, 2017 | 9 | 2017 |
| Expression, Purification and Functional Assessment of Smallest Isoform of Human Interleukin-24 in Escherichia coli S Valiyari, R Mahdian, M Salami, M Oloomi, M Golshani, MA Shokrgozar, ... Brazilian Archives of Biology and Technology 60, e17160621, 2017 | 5 | 2017 |
| In silico design of truncated Omp31 protein of Brucella melitensis: Its cloning and high level expression in Escherichia coli M Golshani, P Zandi, S Bouzari Vaccine Research 1 (1), 16-20, 2014 | 5 | 2014 |
| SARS-CoV-2 specific humoral immune responses after BNT162b2 vaccination in hospital healthcare workers M Golshani, LM Svobodová, L Štěpánek, J Zeman, P Nytrová, H Posová, ... Vaccines 10 (12), 2038, 2022 | 3 | 2022 |
| In silico design, and in vitro expression of a fusion protein encoding Brucella abortus L7/L12 and SOmp2b antigens M Golshani, M Ghasemian, N Gheibi, S Bouzari Advanced Biomedical Research 7 (1), 21, 2018 | 3 | 2018 |
